A patient who developed paralytic ileus while on atropine therapy is described, and this complication of atropine-like drugs is reviewed.
Introduction
Drugs are an important cause of paralytic ileus and failure to recognize this may lead to unnecessary laparotomy. Atropine is an anti-muscarinic alkaloid and its action in decreasing the motility ofintestine is well known.
However, paralytic ileus as a complication of atropine therapy has not to my knowledge previously been reported.
Case report
A 77-year-old man was admitted from a nearby geriatric unit with a 24-hr history of vomiting and epigastric pain. He However, earlier literature suggests that often the dosage and the length of therapy do not play a significant part in the development of the ileus for ganglion blocking drugs (Munster and Milton, 1961) or amitriptyline (Milner and Buckler, 1964) . The case described here would appear to support this view.
Anti-cholinergic activity is a property of many drugs and most notably the tricyclic anti-depressants have been reported as causing paralytic ileus (Milner and Buckler, 1964; Milner and Hills, 1966) .
Phenothiazines, specifically chlorpromazine, are also a recognized cause, thought to be due to their weak atropinic properties (Sriram et al., 1979) . However, with this latter group of drugs it is thought that the development of the ileus is dose related, as it is most often seen in the mentally disturbed patient who may be on huge doses of chlorpromazine. Haloperidol, another neuroleptic drug has also been incriminated (Maltbie et al., 1981) . Phenothiazines may also act to cause ileus via their anti-histaminic properties. Histamine is thought to act directly or indirectly to stimulate gastrointestinal motility (George, 1980) (Simpson, 1978) , and thus patients receiving anticholinergic therapy for Parkinson's disease are more prone to ileus by the very nature of their disease (Daggett and Ibrahim, 1976 (Goodman and Gilman, 1980) . Postoperatively ileus may be prolonged due to concomitant anti-cholinergic therapy being taken by the patient on admission.
Treatment of established anti-cholinergic induced ileus is conservative, as in this case. Little has been published on the effect of the use of anti-cholinesterase drugs such as neostigmine in these patients, although Sriram et al. (1979) have had some success with these drugs and it would seem sound practice to institute such therapy. 
